Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 797.05
-5.10 (-0.64%)
At close: Jul 31, 2026
Alembic Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 73,449 | 73,449 | 66,721 | 62,286 | 56,526 | 53,058 |
Revenue Growth | 10.08% | 10.08% | 7.12% | 10.19% | 6.54% | -1.62% |
Gross Profit Gross Profit Growth | 52,660 | 52,660 | 47,912 | 44,325 | 38,778 | 38,076 |
Operating Income Operating Income Growth | 7,970 | 7,970 | 7,298 | 6,607 | 4,378 | 5,875 |
Net Income Net Income Growth | 6,748 | 6,748 | 5,834 | 6,158 | 3,420 | 5,209 |
Earnings Per Share EPS Growth | 34.33 | 34.33 | 29.68 | 31.33 | 17.40 | 26.50 |
EPS Growth | 15.66% | 15.66% | -5.26% | 80.07% | -34.35% | -55.22% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 27,452 | 27,452 | 26,184 | 24,839 | 23,137 | 21,209 |
Outside India Outside India Growth | 45,997 | 45,997 | 40,537 | 37,448 | 33,390 | 31,109 |
Total Total Growth | 73,449 | 73,449 | 66,721 | 62,286 | 56,526 | 53,058 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,964 | 1,964 | 834.8 | 1,202 | 754.8 | 610.9 |
Total Debt Total Debt Growth | 14,299 | 14,299 | 12,575 | 5,132 | 7,220 | 7,171 |
Net Cash (Debt) Net Cash Growth | -12,336 | -12,336 | -11,740 | -3,930 | -6,465 | -6,560 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -62.76 | -62.76 | -59.73 | -19.99 | -32.89 | -33.37 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 7,827 | 7,827 | 879.7 | 8,032 | 7,240 | 5,524 |
Capital Expenditures CapEx Growth | -4,346 | -4,346 | -5,636 | -3,275 | -4,434 | -4,256 |
Free Cash Flow Free Cash Flow Growth | 3,481 | 3,481 | -4,757 | 4,757 | 2,805 | 1,267 |
Free Cash Flow Growth | - | - | - | 69.58% | 121.40% | -84.24% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 71.69% | 71.69% | 71.81% | 71.16% | 68.60% | 71.76% |
Operating Margin | 10.85% | 10.85% | 10.94% | 10.61% | 7.75% | 11.07% |
Pretax Margin | 9.45% | 9.45% | 10.60% | 10.14% | 6.27% | 11.79% |
Profit Margin | 9.19% | 9.19% | 8.74% | 9.89% | 6.05% | 9.82% |
FCF Margin | 4.74% | 4.74% | -7.13% | 7.64% | 4.96% | 2.39% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 12.000 | 12.000 | 11.000 | 11.000 | 8.000 | 10.000 |
Dividend Per Share Growth | 9.09% | 9.09% | 0% | 37.50% | -20.00% | -28.57% |
Dividend Yield | 1.51% | 1.84% | 1.21% | 1.16% | 1.69% | 1.44% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 23.22 | 19.32 | 31.33 | 31.43 | 28.53 | 27.98 |
P/FCF Ratio | 45.01 | 37.45 | - | 40.69 | 34.78 | 115.04 |
PS Ratio | 2.13 | 1.78 | 2.74 | 3.11 | 1.73 | 2.75 |